williamÍþÁ®ÑÇÖÞ¹Ù·½

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞ·þÎñ×Éѯ £¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
Customer Center
¿Í»§ÖÐÐÄ

»ùÒòÆôÃ÷iNKTϸ°û×¢ÉäÒºµÚÈý¸öINDÉêÇë»ñÅú | 1·ÖÖÓÒ©ÎÅËÙÀÀ Ò½ÏßÒ©ÎÅ

2024-12-09
|
»á¼ûÁ¿£º

΢ÐÅͼƬ_20241202165307_¸±±¾.jpg

Ò½ÏßÒ©ÎÅ

1. ¿ËÈÕ £¬CDE¹ÙÍø¹«Ê¾ £¬±±¾©»ùÒòÆôÃ÷ÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾µÄ1ÀàÁ¢ÒìÒ©--¡°GKL-006£¨iNKTϸ°û×¢ÉäÒº£©¡±µÚÈý¸öÐÂÒ©ÁÙ´²ÊÔÑ飨IND£©»ñµÃ¹ú¼ÒÒ©Æ·¼àÊÓÖÎÀí¾Ö£¨NMPA£©Åú×¼ £¬Ë³Ó¦Ö¢ÎªÓÃÓÚÖÎÁÆÍíÆÚÒÈÏÙ°©¡£

2. 12ÔÂ6ÈÕ £¬ÖØÇ쾫׼ÉúÎï×ÔÖ÷Ñз¢µÄMC-1-50ϸ°ûÖƼÁ»ñCDEĬʾÔÊÐí¿ªÕ¹ÁÙ´²ÊÔÑé £¬ÓÃÓÚÖÎÁÆ¡Ý18ÖÜËêÄÑÖÎÐÔϵͳÐÔºì°ßÀÇ´¯¡£×èÖ¹ÏÖÔÚ £¬¾«×¼ÉúÎïÒÑ»ñµÃ4¸öCAR-Tϸ°û¹ú¼ÒIÀàÉúÎïÐÂÒ©ÁÙ´²Åú¼þ £¬ÁýÕÖѪҺÖ×Áö¡¢ÊµÌåÖ×Áö¡¢×ÔÉíÃâÒß¼²²¡µÈ10Ïî˳Ӧ֢¡£

3. ¿ËÈÕ £¬Ò׼·åÉúÎïÐû²¼ £¬×ÔÖ÷Ñз¢µÄ°ÐÏòCLDN 18.2µÄ×ÔÌåCAR-T²úÆ·IMC002ÒÑ»ñµÃÃÀ¹úFDAÊÚÓèµÄ¿ìËÙͨµÀ×ʸñ£¨Fast Track Designation, FTD£© £¬ÓÃÓÚÖÎÁƲ»¿ÉÇгýµÄ¾Ö²¿ÍíÆÚ¡¢¸´·¢»òתÒÆÐÔCLDN 18.2ÑôÐÔθ°©»¼Õß¡£

4. 12ÔÂ9ÈÕ £¬ÁÙ´²½×¶ÎÉúÎïÒ½Ò©¹«Ë¾ÌØ¿ÆÂÞÉúÎï¿Æ¼¼£¨³É¶¼£©ÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ¡°ÌØ¿ÆÂÞ¡±£©ÕýʽÐû²¼ÐÂÎÅ£ºÌØ¿ÆÂÞ¹«Ë¾Õë¶ÔÌØÓ¦ÐÔƤÑס¢ÊªÕîµÄJak1/Tyk2Ë«°ÐµãÒÖÖƼÁTDM-180935ÍâÓÃÈí¸àµÄÁÙ´²I/IIaÊÔÑéÉêÇëÒÑÓÚ½üÆÚ»ñµÃÖйú¹ú¼ÒÒ©¼à¾ÖÅú×¼¡£

ͶÈÚÒ©ÊÂ

1. 12ÔÂ4ÈÕ £¬ÖÐÒ©Ìù¸à¼ÁÁúÍ·ÁçÈñÖÆÒ©Ðû²¼Í¨¸æ £¬Åû¶һÏî¹ÉȨÊÕ¹ºÒâÏòЭÒéµÄÇ©Êð¡£Í¨¸æÖ¸³ö £¬¹«Ë¾ÄâʹÓÃ×ÔÓÐ×ʽðÊÕ¹ºÒø¹ÈÖÆÒ©ÓÐÏÞÔðÈι«Ë¾100%µÄ¹ÉȨ £¬Æ¾Ö¤¹«Ë¾Ä¿½ñ¶Ô±êµÄ¹«Ë¾ÓªÒµ¡¢²ÆÎñ¼°ÍŶӵÈÇéÐεÄÆðÔ´ÆÀ¹À £¬Æä×ۺϹÀÖµÔݶ¨Îª²»Áè¼Ý7.82ÒÚÔª¡£

2. 12ÔÂ7ÈÕ £¬Å·ÃËίԱ»áÕýʽÎÞÌõ¼þÅú×¼ÁËŵºÍŵµÂ×Ó¹«Ë¾Novo Holdings¶ÔCGT CDMOÁúÍ·¹«Ë¾CatalentµÄÊÕ¹º°¸¡£¾ÝϤ £¬ÆäÊÕ¹º×ܼ۸ߴï165ÒÚÃÀÔª£¨Ô¼1190ÒÚÈËÃñ±Ò£©¡£

¿Æ¼¼Ò©ÑÐ

1. ¿ËÈÕ £¬ÃÀ¹ú¼ÓÖÝ´óѧ¾É½ðɽ·ÖУϸ°ûºÍ·Ö×ÓÒ©ÀíѧϵµÄJack TauntonÍŶÓÔÚNatureÉϽÒÏþÁËÌâΪ Mutant-selective AKT inhibition through lysine targeting and neo-zinc chelation µÄÑо¿ÐÔÂÛÎÄ¡£¸ÃÑо¿Ê¹ÓÃÀ䶳µç¾µÆÊÎöºÍÅÌËã»ú½¨Ä£µÈÊÖ¶ÎÕë¶ÔAKT1 (E17K) Í»±äÉè¼ÆÁËȫеÄÌØÒìÐÔ±ð¹¹ÐÔÒÖÖƼÁ £¬ÎªAKT1 (E17K) Í»±äÏà¹ØÖ×ÁöµÄÖÎÁÆÌṩÁËÐÂ˼Ð÷¡£

[1] Craven, G.B., Chu, H., Sun, J.D. et al. Mutant-selective AKT inhibition through lysine targeting and neo-zinc chelation. Nature (2024). https://doi.org/10.1038/s41586-024-08176-4

Ïà¹ØÐÂÎÅ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
ÍøÕ¾µØͼ
ÓÑÇéÁ´½Ó£ºcq9µç×Ó  fun88¹ÙÍø  js1996¹ÙÍø  AGÆì½¢Ìü  k1ÌåÓý  Ôƶ¦¹ú¼Ê4118  tyc131Ì«Ñô¼¯ÍųǠ k1ÌåÓý  yd2333Ôƶ¥µç×ÓÓÎÏ·  orangeƽ̨  ±ØÒ»Ô˶¯  WMÕæÈËWMÊÓѶ  k1ÌåÓý  ÄÉÃ×ÌåÓý  Z6×ðÁú